Skip to main content
Watch Insiders
TRAXSector not reported

First Tracks Biotherapeutics, Inc. (TRAX) Insider Trading

In the last 90 days, 1 First Tracks Biotherapeutics, Inc. (TRAX) insider reported no open-market purchases and 1 sale totaling $1,758,145. Source: SEC Form 4 filings.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Sep 2, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 2, 2026J. Anthony WareDirectorSale39,265$44.78$1,758,145
Apr 20, 2026EcoR1 Capital LLCCorporate insiderSale4,705,575$13.81$64,999,990

Common questions

TRAX insider trading FAQ

Are TRAX insiders buying or selling?
Over the last 90 days, TRAX insiders were net sellers, reporting $0.00 of open-market purchases and $1,758,145 of sales.
When was the last TRAX insider purchase?
No open-market insider purchase of First Tracks Biotherapeutics, Inc. stock was reported in the last 90 days.
Where does TRAX insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that First Tracks Biotherapeutics, Inc. officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.